Clinical Trials
9
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
A Study to Evaluate Safety and Tolerability of Different Doses and Efficacy of PQ912 in Subjects With MCI and Mild AD
- Conditions
- Mild Cognitive Impairment Due to ADEarly Alzheimers Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2020-08-04
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- Vivoryon Therapeutics N.V.
- Target Recruit Count
- 259
- Registration Number
- NCT04498650
- Locations
- 🇩🇰
Sanos Clinics, Vejle, Denmark
🇩🇪Charité - Universitätsmedizin Berlin, Berlin, Germany
🇩🇪Universitätsklinikum Schleswig-Holstein (UKSH), Klinik für Neurologie, Kiel, Germany
A Trial to Evaluate the Efficacy and Safety of PQ912 in Patients With Early AD
- First Posted Date
- 2019-04-18
- Last Posted Date
- 2025-07-08
- Lead Sponsor
- Vivoryon Therapeutics N.V.
- Target Recruit Count
- 112
- Registration Number
- NCT03919162
- Locations
- 🇺🇸
Barrow Neurological Institute, Phoenix, Arizona, United States
🇺🇸Banner Sun Health Research Institute, Sun City, Arizona, United States
🇺🇸The Neuron Clinic, Chula Vista, California, United States
Safety and Tolerability of PQ912 in Subjects With Early Alzheimer's Disease
- Conditions
- Alzheimer's Disease
- Interventions
- Other: PlaceboDrug: PQ912 oral
- First Posted Date
- 2015-03-17
- Last Posted Date
- 2017-06-01
- Lead Sponsor
- Vivoryon Therapeutics N.V.
- Target Recruit Count
- 120
- Registration Number
- NCT02389413
- Locations
- 🇧🇪
Ziekenhuis Netwerk Antwerpen / Geheugenkliniek, Hoboken, Belgium
🇫🇮Kliininen tutkimuskeskus, Kuopio, Finland
🇫🇮Oulu University Hospital, Oulu, Finland
Effects of PQ912 on the Pharmacokinetics of Midazolam and Omeprazole
- Conditions
- Pharmacologic ActionHealthy Volunteers
- Interventions
- First Posted Date
- 2014-07-15
- Last Posted Date
- 2015-10-21
- Lead Sponsor
- Vivoryon Therapeutics N.V.
- Target Recruit Count
- 18
- Registration Number
- NCT02190708
- Locations
- 🇬🇧
Covance Clinical Research Unit Ltd, Leeds, United Kingdom